Ligand validation:7BHN

NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose

NDG is a Ligand Of Interest in 7BHN designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7BHN_NDG_A_201	62%	90%	0.093	0.885	0.2	0.4	-	-	0	0	100%	0.89
9MP8_NDG_A_201	90%	40%	0.065	0.948	0.66	1.66	-	4	0	0	100%	0.9
9MPA_NDG_A_201	88%	46%	0.064	0.94	0.7	1.35	-	4	0	0	100%	0.97
8DCV_NDG_A_208	70%	41%	0.114	0.93	0.6	1.66	-	5	5	0	100%	0.95
9MP9_NDG_A_201	70%	40%	0.089	0.904	0.7	1.61	-	4	1	0	100%	0.87
9MP7_NDG_A_201	43%	33%	0.115	0.835	0.7	1.94	-	5	0	0	100%	0.86
2ZUV_NDG_B_2002	100%	55%	0.036	0.982	0.59	1.14	-	2	0	0	100%	1
4OCJ_NDG_A_401	99%	66%	0.042	0.978	0.55	0.75	-	-	0	0	100%	1
2ZUW_NDG_A_4001	98%	56%	0.048	0.973	0.59	1.08	-	1	0	0	100%	1
3MAW_NDG_A_519	98%	71%	0.042	0.973	0.52	0.61	-	-	0	0	93%	1
4GVF_NDG_A_401	97%	29%	0.06	0.978	1.66	1.18	4	2	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.